In the context of our recent work, in which we found USP44 to promote the malignant phenotype of the childhood cancer neuroblastoma, we performed this proteomic analysis in the widely used neuroblastoma cell line SH-SY5Y. This evidence concerns the gene USP44 and neuroblastoma.